Eluvia™ peripheral stent system for the treatment of peripheral lesions above the knee

Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal ArteryCLINICAL PERSPECTIVE

(2016) Michael D. Dake et al.   CIRCULATION

Bone Like Arterial Calcification in Femoral Atherosclerotic Lesions: Prevalence and Role of Osteoprotegerin and Pericytes

(2016) J.-M. Davaine et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Drug-Coated Balloons for Complex Femoropopliteal Lesions

(2016) Andrej Schmidt et al.   JACC-Cardiovascular Interventions

Invasive evaluation of plaque morphology of symptomatic superficial femoral artery stenoses using combined near-infrared spectroscopy and intravascular ultrasound

(2016) Sibin K Zacharias et al.   VASCULAR MEDICINE

Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions

(2015) John R. Laird et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

(2015) Kenneth Rosenfield et al.   NEW ENGLAND JOURNAL OF MEDICINE

Novel Approaches to the Management of Advanced Peripheral Artery Disease: Perspectives on Drug-Coated Balloons, Drug-Eluting Stents, and Bioresorbable Scaffolds

(2015) Thomas Zeller et al.   Current Cardiology Reports

The LEVANT I (Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis) Trial for Femoropopliteal Revascularization

(2014) Dierk Scheinert et al.   JACC-Cardiovascular Interventions

Nitinol Stent Implantation in the Superficial Femoral Artery and Proximal Popliteal Artery: Twelve-Month Results From the Complete SE Multicenter Trial

(2014) John R. Laird et al.   JOURNAL OF ENDOVASCULAR THERAPY

2-Year Results of Paclitaxel-Eluting Balloons for Femoropopliteal Artery Disease

(2013) Antonio Micari et al.   JACC-Cardiovascular Interventions

4-French–Compatible Endovascular Material Is Safe and Effective in the Treatment of Femoropopliteal Occlusive Disease: Results of the 4-EVER Trial

(2013) Marc Bosiers et al.   JOURNAL OF ENDOVASCULAR THERAPY

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

(2013) Michael D. Dake et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis

(2013) F Gerald R Fowkes et al.   LANCET

Plaque characteristics and arterial remodeling in coronary and peripheral arterial systems

(2012) Yoshiki Matsuo et al.   ATHEROSCLEROSIS

Paclitaxel-Coated Balloons Reduce Restenosis After Femoro-Popliteal Angioplasty

(2012) Michael Werk et al.   Circulation-Cardiovascular Interventions

Clinical Evaluation of a Paclitaxel-Eluting Balloon for Treatment of Femoropopliteal Arterial Disease

(2012) Antonio Micari et al.   JACC-Cardiovascular Interventions

Nitinol Stent Implantation vs. Balloon Angioplasty for Lesions in the Superficial Femoral and Proximal Popliteal Arteries of Patients With Claudication: Three-Year Follow-up From the RESILIENT Randomized Trial

(2012) John R. Laird et al.   JOURNAL OF ENDOVASCULAR THERAPY

Timing of the restenosis following nitinol stenting in the superficial femoral artery and the factors associated with early and late restenoses

(2011) Osamu Iida et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease

(2011) Michael D. Dake et al.   Circulation-Cardiovascular Interventions

Nitinol Stents With Polymer-Free Paclitaxel Coating for Lesions in the Superficial Femoral and Popliteal Arteries Above the Knee:Twelve-Month Safety and Effectiveness Results From the Zilver PTX Single-Arm Clinical Study

(2011) Michael D. Dake et al.   JOURNAL OF ENDOVASCULAR THERAPY

A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent

(2011) Gregg W. Stone et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease

(2011) Johannes Lammer et al.   JOURNAL OF VASCULAR SURGERY

Vascular Hospitalization Rates and Costs in Patients With Peripheral Artery Disease in the United States

(2010) Elizabeth M. Mahoney et al.  

Vascular response to a third generation everolimus-eluting stent

(2010) Gregory Wilson et al.   EuroIntervention

Endothelial cell recovery, acute thrombogenicity, and monocyte adhesion and activation on fluorinated copolymer and phosphorylcholine polymer stent coatings

(2009) Shawn L. Chin-Quee et al.   BIOMATERIALS

Nitinol Stent Implantation in Long Superficial Femoral Artery Lesions: 12-Month Results of the DURABILITY I Study

(2009) Marc Bosiers et al.   JOURNAL OF ENDOVASCULAR THERAPY